Hmdb loader
You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on Human Metabolome Database.
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2012-09-06 15:16:49 UTC
Update Date2020-02-26 21:39:46 UTC
HMDB IDHMDB0014503
Secondary Accession Numbers
  • HMDB14503
Metabolite Identification
Common NameSulfadiazine
DescriptionSulfadiazine is only found in individuals that have used or taken this drug. It is one of the short-acting sulfonamides used in combination with pyrimethamine to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections. [PubChem]Sulfadiazine is a competitive inhibitor of the bacterial enzyme dihydropteroate synthetase. This enzyme is needed for the proper processing of para-aminobenzoic acid (PABA) which is essential for folic acid synthesis. The inhibited reaction is necessary in these organisms for the synthesis of folic acid.
Structure
Data?1582753186
Synonyms
ValueSource
2-SulfanilamidopyrimidineChEBI
2-SulfanilylaminopyrimidineChEBI
4-Amino-N-2-pyrimidinylbenzenesulfonamideChEBI
N(1)-2-PyrimidinylsulfanilamideChEBI
N(1)-2-PyrimidylsulfanilamideChEBI
SulfadiazinChEBI
SulfadiazinaChEBI
SulfadiazinumChEBI
SulfapyrimidineChEBI
SulphadiazineChEBI
2-SulphanilamidopyrimidineGenerator
2-SulphanilylaminopyrimidineGenerator
4-Amino-N-2-pyrimidinylbenzenesulphonamideGenerator
N(1)-2-PyrimidinylsulphanilamideGenerator
N(1)-2-PyrimidylsulphanilamideGenerator
SulphadiazinGenerator
SulphadiazinaGenerator
SulphadiazinumGenerator
SulphapyrimidineGenerator
SDAHMDB
SulfadiazeneHMDB
SulfanilamidopyrimidineHMDB
SulfapirimidinHMDB
SulfapyrimidinHMDB
SulfazinHMDB
Zinc sulfadiazineHMDB
Sulfadiazine, zincHMDB
SulfazineHMDB
Chemical FormulaC10H10N4O2S
Average Molecular Weight250.277
Monoisotopic Molecular Weight250.052446274
IUPAC Name4-amino-N-(pyrimidin-2-yl)benzene-1-sulfonamide
Traditional Namesulfadiazine
CAS Registry Number68-35-9
SMILES
NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=N1
InChI Identifier
InChI=1S/C10H10N4O2S/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10/h1-7H,11H2,(H,12,13,14)
InChI KeySEEPANYCNGTZFQ-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as aminobenzenesulfonamides. These are organic compounds containing a benzenesulfonamide moiety with an amine group attached to the benzene ring.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassBenzenesulfonamides
Direct ParentAminobenzenesulfonamides
Alternative Parents
Substituents
  • Aminobenzenesulfonamide
  • Benzenesulfonyl group
  • Aniline or substituted anilines
  • Pyrimidine
  • Organosulfonic acid amide
  • Organic sulfonic acid or derivatives
  • Organosulfonic acid or derivatives
  • Heteroaromatic compound
  • Aminosulfonyl compound
  • Sulfonyl
  • Azacycle
  • Organoheterocyclic compound
  • Amine
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Organic oxygen compound
  • Primary amine
  • Organosulfur compound
  • Organonitrogen compound
  • Organic nitrogen compound
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External Descriptors
Ontology
Disposition

Biological location

Source

Route of exposure

Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water Solubility0.6 g/LNot Available
LogP-0.2Not Available
Experimental Chromatographic Properties

Experimental Collision Cross Sections

Adduct TypeData SourceCCS Value (Å2)Reference
[M+H]+Not Available150.893http://allccs.zhulab.cn/database/detail?ID=AllCCS00000815
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.6 g/LALOGPS
logP10(0.25) g/LALOGPS
logP10(0.39) g/LChemAxon
logS10(-2.6) g/LALOGPS
pKa (Strongest Acidic)6.99ChemAxon
pKa (Strongest Basic)2.01ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area97.97 ŲChemAxon
Rotatable Bond Count2ChemAxon
Refractivity64.2 m³·mol⁻¹ChemAxon
Polarizability24.39 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+156.88431661259
DarkChem[M-H]-158.06831661259

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
SulfadiazineNC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=N14014.8Standard polar33892256
SulfadiazineNC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=N12541.9Standard non polar33892256
SulfadiazineNC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=N12455.1Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Sulfadiazine,1TMS,isomer #1C[Si](C)(C)NC1=CC=C(S(=O)(=O)NC2=NC=CC=N2)C=C12662.4Semi standard non polar33892256
Sulfadiazine,1TMS,isomer #1C[Si](C)(C)NC1=CC=C(S(=O)(=O)NC2=NC=CC=N2)C=C12397.6Standard non polar33892256
Sulfadiazine,1TMS,isomer #1C[Si](C)(C)NC1=CC=C(S(=O)(=O)NC2=NC=CC=N2)C=C13639.0Standard polar33892256
Sulfadiazine,1TMS,isomer #2C[Si](C)(C)N(C1=NC=CC=N1)S(=O)(=O)C1=CC=C(N)C=C12472.6Semi standard non polar33892256
Sulfadiazine,1TMS,isomer #2C[Si](C)(C)N(C1=NC=CC=N1)S(=O)(=O)C1=CC=C(N)C=C12366.9Standard non polar33892256
Sulfadiazine,1TMS,isomer #2C[Si](C)(C)N(C1=NC=CC=N1)S(=O)(=O)C1=CC=C(N)C=C13803.6Standard polar33892256
Sulfadiazine,2TMS,isomer #1C[Si](C)(C)N(C1=CC=C(S(=O)(=O)NC2=NC=CC=N2)C=C1)[Si](C)(C)C2524.4Semi standard non polar33892256
Sulfadiazine,2TMS,isomer #1C[Si](C)(C)N(C1=CC=C(S(=O)(=O)NC2=NC=CC=N2)C=C1)[Si](C)(C)C2480.5Standard non polar33892256
Sulfadiazine,2TMS,isomer #1C[Si](C)(C)N(C1=CC=C(S(=O)(=O)NC2=NC=CC=N2)C=C1)[Si](C)(C)C3478.7Standard polar33892256
Sulfadiazine,2TMS,isomer #2C[Si](C)(C)NC1=CC=C(S(=O)(=O)N(C2=NC=CC=N2)[Si](C)(C)C)C=C12482.0Semi standard non polar33892256
Sulfadiazine,2TMS,isomer #2C[Si](C)(C)NC1=CC=C(S(=O)(=O)N(C2=NC=CC=N2)[Si](C)(C)C)C=C12468.7Standard non polar33892256
Sulfadiazine,2TMS,isomer #2C[Si](C)(C)NC1=CC=C(S(=O)(=O)N(C2=NC=CC=N2)[Si](C)(C)C)C=C13331.6Standard polar33892256
Sulfadiazine,3TMS,isomer #1C[Si](C)(C)N(C1=CC=C(S(=O)(=O)N(C2=NC=CC=N2)[Si](C)(C)C)C=C1)[Si](C)(C)C2395.2Semi standard non polar33892256
Sulfadiazine,3TMS,isomer #1C[Si](C)(C)N(C1=CC=C(S(=O)(=O)N(C2=NC=CC=N2)[Si](C)(C)C)C=C1)[Si](C)(C)C2577.7Standard non polar33892256
Sulfadiazine,3TMS,isomer #1C[Si](C)(C)N(C1=CC=C(S(=O)(=O)N(C2=NC=CC=N2)[Si](C)(C)C)C=C1)[Si](C)(C)C3184.8Standard polar33892256
Sulfadiazine,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC1=CC=C(S(=O)(=O)NC2=NC=CC=N2)C=C12885.7Semi standard non polar33892256
Sulfadiazine,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC1=CC=C(S(=O)(=O)NC2=NC=CC=N2)C=C12625.4Standard non polar33892256
Sulfadiazine,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC1=CC=C(S(=O)(=O)NC2=NC=CC=N2)C=C13699.1Standard polar33892256
Sulfadiazine,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)N(C1=NC=CC=N1)S(=O)(=O)C1=CC=C(N)C=C12690.6Semi standard non polar33892256
Sulfadiazine,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)N(C1=NC=CC=N1)S(=O)(=O)C1=CC=C(N)C=C12583.5Standard non polar33892256
Sulfadiazine,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)N(C1=NC=CC=N1)S(=O)(=O)C1=CC=C(N)C=C13779.6Standard polar33892256
Sulfadiazine,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C1=CC=C(S(=O)(=O)NC2=NC=CC=N2)C=C1)[Si](C)(C)C(C)(C)C3004.4Semi standard non polar33892256
Sulfadiazine,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C1=CC=C(S(=O)(=O)NC2=NC=CC=N2)C=C1)[Si](C)(C)C(C)(C)C2900.8Standard non polar33892256
Sulfadiazine,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C1=CC=C(S(=O)(=O)NC2=NC=CC=N2)C=C1)[Si](C)(C)C(C)(C)C3499.4Standard polar33892256
Sulfadiazine,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC1=CC=C(S(=O)(=O)N(C2=NC=CC=N2)[Si](C)(C)C(C)(C)C)C=C12866.1Semi standard non polar33892256
Sulfadiazine,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC1=CC=C(S(=O)(=O)N(C2=NC=CC=N2)[Si](C)(C)C(C)(C)C)C=C12909.0Standard non polar33892256
Sulfadiazine,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC1=CC=C(S(=O)(=O)N(C2=NC=CC=N2)[Si](C)(C)C(C)(C)C)C=C13407.4Standard polar33892256
Sulfadiazine,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C1=CC=C(S(=O)(=O)N(C2=NC=CC=N2)[Si](C)(C)C(C)(C)C)C=C1)[Si](C)(C)C(C)(C)C3039.6Semi standard non polar33892256
Sulfadiazine,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C1=CC=C(S(=O)(=O)N(C2=NC=CC=N2)[Si](C)(C)C(C)(C)C)C=C1)[Si](C)(C)C(C)(C)C3249.6Standard non polar33892256
Sulfadiazine,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C1=CC=C(S(=O)(=O)N(C2=NC=CC=N2)[Si](C)(C)C(C)(C)C)C=C1)[Si](C)(C)C(C)(C)C3328.1Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Sulfadiazine GC-MS (Non-derivatized) - 70eV, Positivesplash10-0f8a-9340000000-39ac1159346610a1332b2017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Sulfadiazine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Sulfadiazine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfadiazine LC-ESI-QTOF , positive-QTOFsplash10-0udi-0090000000-1bc83eabade65dc8953a2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfadiazine LC-ESI-QTOF , positive-QTOFsplash10-0a4i-0910000000-bd163c77861c5a8afa492017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfadiazine LC-ESI-QTOF , positive-QTOFsplash10-0a4i-0900000000-260a572b5c7f3c070c262017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfadiazine LC-ESI-QTOF , positive-QTOFsplash10-052r-0900000000-580f983ba25c4cb3eb302017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfadiazine LC-ESI-ITFT , positive-QTOFsplash10-0a4i-1900000000-8dc8c152ec6044f1c2e92017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfadiazine LC-ESI-ITFT , positive-QTOFsplash10-0udi-0090000000-23afa7ea3ef67a93a2e62017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfadiazine LC-ESI-ITFT , positive-QTOFsplash10-0pb9-3960000000-355dcad6c59ae9c75fb72017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfadiazine LC-ESI-ITFT , positive-QTOFsplash10-0a4i-4900000000-337c5e4fc08cc648b85d2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfadiazine LC-ESI-ITFT , positive-QTOFsplash10-0a4l-8900000000-63cd0dba3c4894d64ae12017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfadiazine LC-ESI-ITFT , positive-QTOFsplash10-0a4l-9500000000-64c8a8332030e3f700a12017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfadiazine LC-ESI-ITFT , positive-QTOFsplash10-05mo-9300000000-746250effd08ec8bf51b2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfadiazine LC-ESI-ITFT , positive-QTOFsplash10-0udi-0090000000-e8005ac37727f1c540d82017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfadiazine LC-ESI-ITFT , positive-QTOFsplash10-0pb9-2960000000-ff127258fb7c09ae36652017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfadiazine LC-ESI-ITFT , positive-QTOFsplash10-0a4i-4900000000-4fa5b350b17254bc9a1a2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfadiazine LC-ESI-ITFT , positive-QTOFsplash10-0a4l-8900000000-4a998ad7772889643c1f2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfadiazine LC-ESI-ITFT , positive-QTOFsplash10-0a4l-9500000000-7e0d8190b4e7f7ced9562017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfadiazine LC-ESI-ITFT , positive-QTOFsplash10-05mo-9300000000-9cca42d677a6ef782a2c2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfadiazine LC-ESI-ITFT , positive-QTOFsplash10-0a4i-1900000000-4b5c2f7e29a6399f475c2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfadiazine 60V, Positive-QTOFsplash10-0a4l-8900000000-63cd0dba3c4894d64ae12021-09-20HMDB team, MONAView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Sulfadiazine 10V, Positive-QTOFsplash10-0ue9-0190000000-67ad2e08ca1d769ef1362016-08-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Sulfadiazine 20V, Positive-QTOFsplash10-0pb9-5690000000-6430cecd9bf7a43ae6492016-08-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Sulfadiazine 40V, Positive-QTOFsplash10-00o0-9010000000-57f00ddb968c873de4ed2016-08-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Sulfadiazine 10V, Negative-QTOFsplash10-0002-0090000000-9a91c28ea8399756ca2b2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Sulfadiazine 20V, Negative-QTOFsplash10-0002-1940000000-4e16dfc23fbb7da4f6482016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Sulfadiazine 40V, Negative-QTOFsplash10-0006-9300000000-d2a79b1ca177af6ee6562016-08-03Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Membrane
Biospecimen Locations
  • Blood
  • Urine
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB00359 details
UrineExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB00359 details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB00359
Phenol Explorer Compound IDNot Available
FooDB IDFDB010662
KNApSAcK IDNot Available
Chemspider ID5026
KEGG Compound IDC07658
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkSulfadiazine
METLIN IDNot Available
PubChem Compound5215
PDB IDNot Available
ChEBI ID9328
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Download (PDF)
General ReferencesNot Available

Enzymes

General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation reactions (e.g. caffeine 8-oxidation, omeprazole sulphoxidation, midazolam 1'-hydroxylation and midazolam 4-hydroxylation) of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,8-cineole 2-exo-monooxygenase. The enzyme also hydroxylates etoposide.
Gene Name:
CYP3A4
Uniprot ID:
P08684
Molecular weight:
57255.585
References
  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. This enzyme contributes to the wide pharmacokinetics variability of the metabolism of drugs such as S-warfarin, diclofenac, phenytoin, tolbutamide and losartan.
Gene Name:
CYP2C9
Uniprot ID:
P11712
Molecular weight:
55627.365
References
  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in monooxygenase activity
Specific function:
Metabolizes several precarcinogens, drugs, and solvents to reactive metabolites. Inactivates a number of drugs and xenobiotics and also bioactivates many xenobiotic substrates to their hepatotoxic or carcinogenic forms.
Gene Name:
CYP2E1
Uniprot ID:
P05181
Molecular weight:
56848.42
References
  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. In the epoxidation of arachidonic acid it generates only 14,15- and 11,12-cis-epoxyeicosatrienoic acids. It is the principal enzyme responsible for the metabolism the anti-cancer drug paclitaxel (taxol).
Gene Name:
CYP2C8
Uniprot ID:
P10632
Molecular weight:
55824.275
References
  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]